Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Surya Fajar Capital Tbk. (SFAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Surya Fajar Capital Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp222 (market cap 308B, 129.6K 24h volume), while Surya Fajar Capital Tbk. trades at Rp1,965 (market cap 2.67T, 47.3K 24h volume). The key difference: Surya Fajar Capital Tbk. is far larger — about 8.7× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (129.6K versus 47.3K). Which is the better fit depends on your goals.
| DGNS | SFAN | |
|---|---|---|
Market Cap | 308B | 2.67T |
Volume | 129.6K | 47.3K |
Lot | 1.3K | 473 |
Turnover | 28.71M | 93.18M |
Average Price | 221.54 | 1,969.92 |
Value | 28.71M | 93.18M |
Indicative Equilibrium Price | 230 | — |
Indicative Equilibrium Volume | 110 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Surya Fajar Capital Tbk.
PT Surya Fajar Capital Tbk (the Company) was established based on Notarial Deed No. 12 dated April 5, 2016 of Humberg Lie, S.H., S.E., M.Kn., a public notary in North Jakarta.
Read more on SFAN →
